The effect of adrenergic compounds on neurogenic dural vasodilatation

This publication has 29 references indexed in Scilit:

• Caudal midline medulla mediates behaviourally-coupled but not baroreceptor-mediated vasodepression
  Neuroscience, 2000
• Migraine
  The Lancet, 1998
• Cardiovascular Effects of Oxymetazoline and UK14,304 in Conscious and Pithed Rats
  Clinical and Experimental Hypertension, 1997
• NK1 receptors mediate tachykinin-induced plasma extravasation in the rat knee joint
  Inflammation Research, 1993
• Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion
  Neuropharmacology, 1991
• Vasoactive peptide release in the extracerebral circulation of humans during migraine headache
  Annals of Neurology, 1990
• The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater
  British Journal of Pharmacology, 1990
• Alpha₁‐ and alpha₂‐adrenoreceptor antagonists produce opposing mydriatic effects by a central action
  Journal of Autonomic Pharmacology, 1988
• Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system
  Annals of Neurology, 1988
• Headache and noradrenergic involvement: the effects of α₂‐stimulants and α₂‐antagonists
  Acta Psychiatrica Scandinavica, 1985